| UEPSX | VEUPX | UEPSX / VEUPX | |
| Total Expense Ratio | 2.78 | 0.05 | 5,560% |
| Annual Report Gross Expense Ratio | 3.53 | 0.05 | 7,060% |
| Fund Existence | 27 years | 12 years | - |
| Gain YTD | 18.815 | 8.739 | 215% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 15000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 9.18M | 37.9B | 0% |
| Annual Yield % from dividends | 0.76 | 2.84 | 27% |
| Returns for 1 year | 37.09 | 20.48 | 181% |
| Returns for 3 years | 68.22 | 45.64 | 149% |
| Returns for 5 years | 70.40 | 33.86 | 208% |
| Returns for 10 years | 131.34 | 95.82 | 137% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AWSRX | 18.00 | 0.10 | +0.56% |
| Invesco Global Core Equity R | |||
| CSXCX | 56.40 | 0.31 | +0.55% |
| Calvert US Large Cap Core Rspnb Idx C | |||
| IVRIX | 32.63 | -0.21 | -0.64% |
| VY® Columbia Real Estate I | |||
| VRTGX | 515.99 | -3.55 | -0.68% |
| Vanguard Russell 2000 Growth Index I | |||
| SHPAX | 22.87 | -0.25 | -1.08% |
| Saratoga Health & Biotechnology A | |||